WuXi XDC Cayman Inc
2268
Classement en actions
#1886
WuXi XDC Cayman Inc. operates as an investment holding company and a global... WuXi XDC Cayman Inc. operates as an investment holding company and a global contract research, development, and manufacturing organization (CRDMO), with operations spanning China, North America, Europe, and other international regions. The company's expertise covers the entire lifecycle, from discovery and research to development and manufacturing, of biopharmaceutical products. Specifically, it focuses on antibody-drug conjugates (ADCs), various bioconjugates, monoclonal antibody intermediates, and the crucial payload-linkers integral to bioconjugate synthesis. Founded in 2013 and headquartered in Wuxi, China, WuXi XDC Cayman Inc. is a subsidiary of WuXi Biologics (Cayman) Inc.
Prix de l'action
$8.78
Capitalisation boursière
$11.12B
Changement (1 jour)
-9.52%
Changement (1 an)
0.57%
Pays
CN
Échange WuXi XDC Cayman Inc (2268)
Catégorie
Healthcare
Historique du prix de l'action pour WuXi XDC Cayman Inc (2268)
Prix de clôture le plus élevé : $10.09 le 2026-10-01
Prix de clôture le plus bas : $3.64 le 2023-11-01
Prix de clôture le plus bas : $3.64 le 2023-11-01
Historique du prix de l'action de WuXi XDC Cayman Inc de 2023 à 2026
Performance annuelle du prix de l'action
| Année | Performance |
|---|---|
| 2026 (TTM) | -3.96% |
| 2025 | 118.28% |
| 2024 | 0.25% |
| 2023 | 0.00% |
Prix de l'action pour des entreprises similaires ou concurrentes
| Entreprise | Prix de l'action | Variation 1a% | Pays |
|---|---|---|---|
| $676.48 | 19.27% |
US
|
|
| $229.93 | 5.42% |
US
|
|
| $398.85 | 112.13% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $174.35 | 19.52% |
US
|
